Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 1.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 180,116 shares of the semiconductor company’s stock after acquiring an additional 2,746 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Lam Research were worth $78,050,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Cedar Mountain Advisors LLC boosted its position in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 85 shares during the period. Vermillion Wealth Management Inc. acquired a new position in shares of Lam Research during the first quarter valued at $26,000. Hughes Financial Services LLC increased its holdings in shares of Lam Research by 54.9% during the second quarter. Hughes Financial Services LLC now owns 141 shares of the semiconductor company’s stock valued at $61,000 after purchasing an additional 50 shares during the period. Bayban bought a new stake in shares of Lam Research during the fourth quarter valued at about $26,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in shares of Lam Research during the fourth quarter valued at about $27,000. Institutional investors own 84.61% of the company’s stock.
Insider Activity
In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares in the company, valued at $29,192,570. This trade represents a 17.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 over the last three months. Insiders own 0.31% of the company’s stock.
Lam Research Trading Up 1.1%
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, research analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.
Wall Street Analyst Weigh In
LRCX has been the subject of a number of recent analyst reports. Seaport Research Partners initiated coverage on shares of Lam Research in a research report on Monday, May 4th. They issued a “buy” rating and a $300.00 target price for the company. Berenberg Bank increased their price target on Lam Research from $265.00 to $335.00 and gave the company a “buy” rating in a research note on Thursday, April 23rd. Wall Street Zen cut Lam Research from a “buy” rating to a “hold” rating in a research report on Sunday, May 10th. Needham & Company LLC reissued a “buy” rating and issued a $390.00 price objective on shares of Lam Research in a research note on Thursday, July 30th. Finally, B. Riley Financial cut their price objective on Lam Research from $385.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $358.47.
Get Our Latest Stock Analysis on Lam Research
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
